ClassID:

2172

A01K2207/12 - page 2 - CPC Classification

Classification description:

Modified animals Animals modified by administration of exogenous cells

Recent Application in this class:
#301
20160296638
2016-10-13

Gene therapy to prevent reactions to allergens

#302
20160295844
2016-10-13

Genetically modified non-human animals and methods of use thereof

#303
20160295841
2016-10-13

Production of fertile XY female animals from XY ES cells

#304
20160257928
2016-09-08

Method for producing pluripotent stem cell having improved chimera forming ability from primed pluripotent stem cell, and composition and combination therefor

#305
20160256681
2016-09-08

Methods of generating mature human muscle fibers

#306
20160256575
2016-09-08

Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis

#307
20160249591
2016-09-01

Fumarylacetoacetate hydrolase (Fah)-deficient and immunodeficient rats and uses thereof

#308
20160235044
2016-08-18

Immune competent models of human disease

#309
20160219843
2016-08-04

Mouse model for engraftment potential

#310
20160193140
2016-07-07

Method for regenerating hair follicles using CD36-expressing dermal sheath cells

#311
20160192626
2016-07-07

Method For Creating Endometriotic Cells And Endometriosis Model Animal

#312
20160177273
2016-06-23

Stem cells for modeling type 2 diabetes

#313
20160174534
2016-06-23

GENETICALLY MODIFIED RAT MODELS FOR PHARMACOKINETICS

#314
20160166713
2016-06-16

Immune-compromised zebrafish

#315
20160158386
2016-06-09

MODEL OF COLORECTAL CANCER

#316
20160157470
2016-06-09

Non-human animals having a humanized cluster of differentiation 47 gene

#317
20160143951
2016-05-26

Dosage compensating transgenes and cells

#318
20160135437
2016-05-19

HUMANIZED MOUSE MODEL FOR STUDY OF BONA FIDE HEPATITIS VIRUS INFECTION AND USE THEREOF

#319
20160106076
2016-04-21

RECOMBINANT NON-HUMAN MAMMALIAN MODEL FOR HEPATITIS INFECTION AND IMMUNOPATHOGENESIS

#320
20160101193
2016-04-14

Use of a truncated CCN1 promoter for cancer diagnostics, therapeutics and theranostics

#321
20160074391
2016-03-17

Means and methods for treating cancer

#322
20160073616
2016-03-17

METHOD FOR PRODUCING CHIMERIC ANIMAL

#323
20160051702
2016-02-25

Systems and methods for preclinical models of metastases

#324
20160050896
2016-02-25

Non-human animals having a humanized signal-regulatory protein gene

#325
20160037757
2016-02-11

Transgenic model for delay-type hypersensitivity (DTH) and use thereof

#326
20160015756
2016-01-21

Cell therapy: a method and a composition for treating diabetes

#327
20150368666
2015-12-24

Designer circuit controlling diet-induced obesity

#328
20150342165
2015-12-03

HUMANIZED MOUSE AND METHODS OF USING THE SAME

#329
20150328339
2015-11-19

Human glial chimeric model for drug candidate assessment in human gliotrophic viral infections and progressive multifocal encephalopathy

#330
20150327524
2015-11-19

Genetically modified non-human animals expressing human EPO

#331
20150283270
2015-10-08

MODELING ANTI-LEUKEMIC THERAPY BY PATIENT DERIVED AML XENOGRAFTS WITH DISTINCT PHENOTYPES/GENOTYPES

#332
20150282460
2015-10-08

ANIMAL MODEL WITH HUMAN IMMUNE SYSTEM

#333
20150282459
2015-10-08

Method of establishing isogenic multi-xenograft model and the use thereof

#334
20150264901
2015-09-24

Model animal for pregnancy-induced hypertension syndrome, and treatment method therefor

#335
20150208622
2015-07-30

Genetically modified non-human animals and methods of use thereof

#336
20150208620
2015-07-30

Obesity animal model and methods for making and using thereof

#337
20150181844
2015-07-02

Fumarylacetoacetate hydrolase (Fah)-deficient pigs and uses thereof

#338
20150175957
2015-06-25

Feeder-free method for culture of bovine and porcine spermatogonial stem cells

#339
20150168375
2015-06-18

CANCER STEM CELLS AND METHODS OF USING THE SAME

#340
20150164053
2015-06-18

Mammal with an orthotopic tumor capable of metastasis, a method of making and a method of using

#341
20150158927
2015-06-11

HLA G-modified cells and methods

#342
20150143561
2015-05-21

Non-human animals having a humanized B-cell activating factor gene

#343
20150143559
2015-05-21

NON-HUMAN ANIMALS HAVING A HUMANIZED A PROLIFERATION-INDUCING LIGAND GENE

#344
20150128298
2015-05-07

Urokinase-type plasminogen activator transgenic mouse

#345
20150105288
2015-04-16

Genetically modified non-human animals and methods relating to innate immune system response detection

#346
20150067901
2015-03-05

Production of fertile XY female animals from XY ES cells

#347
20150056636
2015-02-26

Transgenic immunodeficient mouse expressing human SIRP-alpha

#348
20150052625
2015-02-19

HUMANIZED MOUSE

#349
20150031856
2015-01-29

Anaplastic lymphoma kinase (ALK) as an oncogene capable of transforming normal human cells

#350
20140350073
2014-11-27

Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer

#351
20140335063
2014-11-13

Delivery methods and compositions for nuclease-mediated genome engineering

#352
20140302155
2014-10-09

Production of a human beta cell line from an early post natal pancreas

#353
20140256917
2014-09-11

Compositions and methods for osteogenic gene therapy

#354
20140255369
2014-09-11

Production and use of red blood cells

#355
20140241991
2014-08-28

Chimeric non-human animal carrying human hepatocyte

#356
20140230080
2014-08-14

Method for inducing hepatocellular variation, and production method for chimeric non-human animal having humanized liver

#357
20140090095
2014-03-27

Genetically modified mice and engraftment

#358
20140086907
2014-03-27

Treatment and bioluminescent visualization using multimodal TRAIL molecules

#359
20130340105
2013-12-19

Human SIRPAalpha transgenic animals and their methods of use

#360
20130302815
2013-11-14

Polynucleotides comprising a reporter sequence operatively linked to a regulatory element

#361
20130298269
2013-11-07

Compositions and methods relating to non-human animals modified to promote production of selected gametes

#362
20130280284
2013-10-24

Modulation of antigen immunogenicity by deleting epitopes recognized by NKT cells

#363
20130239239
2013-09-12

LMCD1 CANCER MARKERS AND METHODS FOR THEIR USE

#364
20130230520
2013-09-05

Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled1, Frizzled2 or Frizzled7 extracellular cysteine-rich domain

#365
20130198874
2013-08-01

Model animal for pregnancy-induced hypertension syndrome, and treatment method therefor

#366
20130195812
2013-08-01

Induced pluripotent stem cells

#367
20130191931
2013-07-25

Fumarylacetoacetate hydrolase (fah)-deficient pigs and uses thereof

#368
20130061342
2013-03-07

Identification and Enrichment of Cell Subpopulations

#369
20130061340
2013-03-07

Identification and Enrichment of Cell Subpopulations

#370
20130047274
2013-02-21

CD4 T-cells and CD8zeta cells involved in mammalian host response to epithelial cell infections and uses thereof

#371
20130042330
2013-02-14

Humanized M-CSF mice

#372
20130024961
2013-01-24

Methods of Modulating Thrombocytopenia and Modified Transgenic Pigs

#373
20130024957
2013-01-24

Genetically modified mice and engraftment

#374
20130022996
2013-01-24

Genetically modified mice and engraftment

#375
20130019327
2013-01-17

Method for searching and screening for target of anti-cancer agent using non-human animal model having NOG established cancer cell line transplanted therein

#376
20130004472
2013-01-03

MEANS AND METHODS FOR IMPROVING THE DEVELOPMENT AND MATURATION OF EGGS AND/OR SPERM IN FISH USING HORMONES PRODUCED BY TRANSPLANTED CELLS

#377
20120283618
2012-11-08

Method of inducing cellular growth and materials for use therewith

#378
20120272346
2012-10-25

Identification of RNAI targets and use of RNAI for rational therapy of chemotherapy-resistant leukemia and other cancers

#379
20120255043
2012-10-04

MicroRNA as a cancer progression predictor and its use for treating cancer

#380
20120251528
2012-10-04

Non-Human Mammal Model Of Human Hematopoietic Cancer

#381
20120219506
2012-08-30

Catenae: Serosal Cancer Stem Cells

#382
20120201794
2012-08-09

DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS

#383
20120184030
2012-07-19

METHODS FOR ESTABLISHING SYMBIOSES

#384
20120167242
2012-06-28

Compositions and methods relating to non-human animals modified to promote production of selected gametes

#385
20120157667
2012-06-21

Methods Of Producing Humanized Non-Human Mammals

#386
20120128594
2012-05-24

Selective infarcted-tissue-targeting bacteria and use thereof

#387
20120095444
2012-04-19

Polynucleotides encoding a human TRIM-Cyp fusion polypeptide, compositions thereof, and methods of using same

#388
20120076754
2012-03-29

Use of IL-17 Polypeptides for Use in the Prevention or Treatment of Atherosclerosis

#389
20120066780
2012-03-15

Humanized NSG mouse, method of producing the same and use thereof

#390
20110307968
2011-12-15

Production of fertile XY animals from XY ES cells

#391
20110262425
2011-10-27

THERAPEUTIC AGENT FOR MLL LEUKEMIA AND MOZ LEUKEMIA OF WHICH MOLECULAR TARGET IS M-CSF RECEPTOR, AND USE THEREOF

#392
20110258715
2011-10-20

ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION

#393
20110237514
2011-09-29

PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN

#394
20110225661
2011-09-15

METHOD FOR TREATING AND PREVENTING RADIATION DAMAGE USING GENETICALLY MODIFIED MESENCHYMAL STEM CELLS

#395
20110200982
2011-08-18

Genetically modified mice and engraftment

#396
20110145936
2011-06-16

Genetically Modified Rat Models for Pharmacokinetics

#397
20110113496
2011-05-12

Transgenic non-human animal and methods for stem cell engraftment

#398
20110085982
2011-04-14

DKAT CELL LINE, A MODEL FOR HUMAN TRIPLE-NEGATIVE BREAST CANCER

#399
20110081717
2011-04-07

Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer

#400
20110041192
2011-02-17

Recombinant non-human mammalian model for hepatitis infection and immunopathogenesis

#401
20110004947
2011-01-06

Compositions and methods for osteogenic gene therapy

#402
20100221232
2010-09-02

Composition and methods for osteogenic gene therapy

#403
20100100977
2010-04-22

Probe for visualizing cell-cycle

#404
20100099638
2010-04-22

Immunocompetent xenograft model

#405
20100037328
2010-02-11

CD20 negatively converted B-cell malignant lymphoma cell line and utilization thereof

#406
20090313710
2009-12-17

Nonalcoholic steatohepatitis model rodent and fatty liver model rodent

#407
20090271884
2009-10-29

ES Cell-Derived Mice From Diploid Host Embryo Injection

#408
20080184378
2008-07-31

Non human animals with human-glial chimeric brains

#409
20080152634
2008-06-26

Means and Methods for Improving the Development and Maturation of Eggs and/or Sperm in Fish Using Hormones Produced by Transplanted Cells

#410
20080078001
2008-03-27

Method for making homozygous genetic modifications

#411
20080078000
2008-03-27

Conditioned culture media

#412
20080028479
2008-01-31

Method for making genetic modifications

#413
20060085866
2006-04-20

Method for generating an animal homozygous for a genetic modification

#414
20050201936
2005-09-15

Models for viral-based cancer therapy

#415
20050196864
2005-09-08

Induction and high-yield preparative purification of mesencephalic dopaminergic neuronal progenitor cells and dopaminergic neurons from human embryonic stem cells